Gynecologic and Obstetric Investigation
Original Article
Risk Factors for Haemorrhage during Suction Curettage after Uterine Artery Embolization for Treating Caesarean Scar Pregnancy: A Case-Control StudyDu Y.J. · Zhang X.H. · Wang L.Q.Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, P.R. China
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: June 18, 2014
Accepted: February 26, 2015
Published online: April 29, 2015
Issue release date: December 2015
Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 4
ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)
For additional information: https://www.karger.com/GOI
Abstract
Aims: To investigate the potential risk factors for haemorrhage during suction curettage after uterine artery embolization (UAE) in the treatment of caesarean scar pregnancy (CSP). Methods: A case-control study was executed including 35 patients with CSP and haemorrhage during suction curettage after UAE and 140 controls without haemorrhage. The data collected included gestational age, the distance between the gestational mass and the bladder, and the volume of vaginal bleeding. Results: Six patients with UAE needed blood transfusions and two had a hysterectomy, while no patient in the control group needed these interventions. Multivariate analysis showed that both gestational age and the distance between the gestational mass and the bladder were associated with haemorrhage in the CSP group. The odds ratio (OR) of gestational age between cases and controls was 1.579 (95% confidence interval [CI] 1.291-1.933), and the OR of the distance between the gestational mass and the bladder was 0.208 (95% CI 0.082-0.531). Conclusion: Increased gestational age might be an important risk factor for haemorrhage during suction curettage after UAE in the treatment of patients with CSP, and a distance of >0.2 cm between the gestational mass and the bladder was protective against haemorrhage.
© 2015 S. Karger AG, Basel
Related Articles:
References
- Larsen JV, Solomon MH: Pregnancy in a uterine scar sacculus - an unusual cause of postabortal haemorrhage. A case report. S Afr Med J 1978;53:142-143.
- Jurkovic D, Hillaby K, Woelfer B, Lawrence A, Salim R, Elson CJ: First-trimester diagnosis and management of pregnancies implanted into the lower uterine segment caesarean section scar. Ultrasound Obstet Gynecol 2003;21:220-227.
- Seow KM, Huang LW, Lin YH, Lin MY, Tsai YL, Hwang JL: Caesarean scar pregnancy: issues in management. Ultrasound Obstet Gynecol 2004;23:247-253.
- Hsieh BC, Hwang JL, Pan HS, Huang SC, Chen CY, Chen PH: Heterotopic Caesarean scar pregnancy combined with intrauterine pregnancy successfully treated with embryo aspiration for selective embryo reduction: case report. Hum Reprod 2004;19:285-287.
- Ash A, Smith A, Maxwell D: Caesarean scar pregnancy. BJOG 2007;114:253-263.
- Shen L, Tan A, Zhu H, Guo C, Liu D, Huang W: Bilateral uterine artery chemoembolization with methotrexate for cesarean scar pregnancy. Am J Obstet Gynecol 2012;207:386.e1-386.e6.
- Le A, Shan L, Xiao T, Zhuo R, Xiong H, Wang Z: Transvaginal surgical treatment of cesarean scar ectopic pregnancy. Arch Gynecol Obstet 2013;287:791-796.
- Zhuang Y, Huang L: Uterine artery embolization compared with methotrexate for the management of pregnancy implanted within a caesarean scar. Am J Obstet Gynecol 2009;201:152.e1-152.e3.
- Li C, Li C, Feng D, Jia C, Liu B, Zhan X: Transcatheter arterial chemoembolization versus systemic methotrexate for the management of cesarean scar pregnancy. Int J Gynaecol Obstet 2011;113:178-182.
- Godin PA, Bassil S, Donnez J: An ectopic pregnancy developing in a previous caesarean section scar. Fertil Steril 1997;67:398-400.
- Lian F, Wang Y, Chen W, Li J, Zhan Z, Ye Y, Zhu Y, Huang J, Xu H, Yang X, Liang L, Yang J: Uterine artery embolization combined with local methotrexate and systemic methotrexate for treatment of cesarean scar pregnancy with different ultrasonographic pattern. Cardiovasc Intervent Radiol 2012;35:286-291.
- Tekin YB, Ural UM, Balik G, Ustuner I, Sahin FK, Guven ESG: Management of cesarean scar pregnancy with suction curettage: a report of four cases and review of the literature. Arch Gynecol Obstet 2014;289:1171-1175.
- Rossavik IK, Torjusen GO, Gibbons WE: Conceptual age and ultrasound measurements of gestational sac and crown-rump length in in vitro fertilization pregnancies. Fertil Steril 1988;49:1012-1017.
- Sahota DS, Leung TY, Leung TN, Chan OK, Lau TK: Foetal crown-rump length and estimation of gestational age in an ethnic Chinese population. Ultrasound Obstet Gynecol 2009;33:157-160.
- Litwicka K, Greco E: Caesarean scar pregnancy: a review of management options. Curr Opin Obstet Gynecol 2013;25:456-461.
- Herman A, Weinraub Z, Avrech O, Maymon R, Ron-El R, Bukovsky Y: Follow-up and outcome of isthmic pregnancy located in a previous caesarean section scar. Br J Obstet Gynaecol 1995;102:839-841.
- Maymon R, Halperin R, Mendlovic S, Schneider D, Herman A: Ectopic pregnancies in a caesarean scar: review of the medical approach to an iatrogenic complication. Hum Reprod Update 2004;10:515-523.
- Zhang Y, Duan H, Cheng JM, Guo YS: Treatment options to terminate persistent cesarean scar pregnancy. Gynecol Obstet Invest 2013;75:115-119.
- Arslan M, Pata O, Dilek TU, Aktas A, Aban M, Dilek S: Treatment of viable cesarean scar ectopic pregnancy with suction curettage. Int J Gynecol Obstet 2005;89:163-166.
- Rotas MA, Haberman S, Levgur M: Cesarean scar ectopic pregnancies: etiology, diagnosis and management. Obstet Gynecol 2006;107:1373-1377.
- Jiang T, Liu G, Huang L, Ma H, Zhang S: Methotrexate therapy followed by suction curettage followed by Foley tamponade for caesarean scar pregnancy. Eur J Obstet Gynecol Reprod Biol 2011;156:209-211.
- Yin X, Su S, Dong B, Ban Y, Li C, Sun B: Angiographic uterine artery chemoembolization followed by vacuum aspiration: an efficient and safe treatment for managing complicated cesarean scar pregnancy. Arch Gynecol Obstet 2012;285:1313-1318.
- Vial Y, Petignat P, Hohlfeld P: Pregnancy in a caesarean scar. Ultrasound Obstet Gynecol 2000;16:592-593.
- Osborn DA, Williams TR, Craig BM: Cesarean scar pregnancy sonographic and magnetic resonance imaging findings, complications, and treatment. J Ultrasound Med 2012;31:1449-1456.
- Shao MJ, Hu MX, Xu XJ, Zhang L, Hu M: Management of caesarean scar pregnancies using an intrauterine or abdominal approach based on the myometrial thickness between the gestational mass and the bladder wall. Gynecol Obstet Invest 2013;76:151-157.
- Timor-Tritsch IE, Monteagudo A, Santos R, Tsymbal T, Pineda G, Arslan AA: The diagnosis, treatment, and follow-up of cesarean scar pregnancy. Am J Obstet Gynecol 2012;207:44.e1-44.e13.
Article / Publication Details
Received: June 18, 2014
Accepted: February 26, 2015
Published online: April 29, 2015
Issue release date: December 2015
Number of Print Pages: 6
Number of Figures: 1
Number of Tables: 4
ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)
For additional information: https://www.karger.com/GOI
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
